Marion H. Jordan
Marion H. Jordan has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Andrey V. Bortsov
Department of Surgery, University of North Carolina, Chapel Hill
2 shared publications - Bruce A. Cairns
The University of North Carolina at Chapel Hill
2 shared publications - James Hwang
Department of Surgery, University of North Carolina, Chapel Hill
2 shared publications - Janelle M. Hoskins
Department of Surgery, University of North Carolina, Chapel Hill
2 shared publications - Jeffrey W. Shupp
Firefighters’ Burn and Surgical Research Laboratory, MedStar Health Research Institute, Washington, DC 20010, USA
2 shared publications - Linwood R. Haith
Crozer Chester Medical Center, Upland, PA
2 shared publications
Latest Publications
- 1 January 2015
- Published by Wolters Kluwer Health in The Clinical Journal of Pain
- Vol. 31 (1) , 21-29
Results of a Pilot Multicenter Genotype-based Randomized Placebo-controlled Trial of Propranolol to Reduce Pain After Major Thermal Burn Injury
Background: Results of previous studies suggest that β-adrenoreceptor activation may augment pain, and that β-adrenoreceptor antagonists may be effective in reducing pain, particularly in individuals not homozygous for the catechol-O-methyltransferase (COMT) high-activity haplotype. Materials and Methods: Consenting patients admitted for thermal burn injury at participating burn centers were genotyped; those who were not high-activity COMT homozygotes were randomized to propranolol 240 mg/d or placebo. Primary outcomes were study feasibility (consent rate, protocol completion rate) and pain scores on study days 5 to 19. Secondary outcomes assessed pain and posttraumatic stress disorder symptoms 6 weeks postinjury. Results: Seventy-seven percent (61/79) of eligible patients were consented and genotyped, and 77% (47/61) were genotype eligible and randomized. Ninety-one percent (43/47) tolerated study drug and completed primary outcome assessments. In intention-to-treat and per-protocol analyses, patients randomized to propranolol had worse pain scores on study days 5 to 19. Conclusions: Genotype-specific pain medication interventions are feasible in hospitalized burn patients. Propranolol is unlikely to be a useful analgesic during the first few weeks after burn injury.
- 1 January 2015
- Published by Wolters Kluwer Health in The Clinical Journal of Pain
- Vol. 31 (1) , 21-29
Results of a Pilot Multicenter Genotype-based Randomized Placebo-controlled Trial of Propranolol to Reduce Pain After Major Thermal Burn Injury
Background: Results of previous studies suggest that β-adrenoreceptor activation may augment pain, and that β-adrenoreceptor antagonists may be effective in reducing pain, particularly in individuals not homozygous for the catechol-O-methyltransferase (COMT) high-activity haplotype. Materials and Methods: Consenting patients admitted for thermal burn injury at participating burn centers were genotyped; those who were not high-activity COMT homozygotes were randomized to propranolol 240 mg/d or placebo. Primary outcomes were study feasibility (consent rate, protocol completion rate) and pain scores on study days 5 to 19. Secondary outcomes assessed pain and posttraumatic stress disorder symptoms 6 weeks postinjury. Results: Seventy-seven percent (61/79) of eligible patients were consented and genotyped, and 77% (47/61) were genotype eligible and randomized. Ninety-one percent (43/47) tolerated study drug and completed primary outcome assessments. In intention-to-treat and per-protocol analyses, patients randomized to propranolol had worse pain scores on study days 5 to 19. Conclusions: Genotype-specific pain medication interventions are feasible in hospitalized burn patients. Propranolol is unlikely to be a useful analgesic during the first few weeks after burn injury.
- 1 January 2012
- Published by Oxford University Press (OUP) in Journal of Burn Care & Research
- Vol. 33 (4) , 518-523
Catechol-O-Methyltransferase Genotype Predicts Pain Severity in Hospitalized Burn Patients
Increasing evidence suggests that stress system activation after burn injury may contribute to burn-related pain. If this is the case, then genetic v
- 1 January 2012
- Published by Oxford University Press (OUP) in Journal of Burn Care & Research
- Vol. 33 (4) , 518-523
Catechol-O-Methyltransferase Genotype Predicts Pain Severity in Hospitalized Burn Patients
Increasing evidence suggests that stress system activation after burn injury may contribute to burn-related pain. If this is the case, then genetic v